RSenateSenator · Arkansas

Sold up to $15,000 of Johnson & Johnson (JNJ)

Name: John Boozman sold $15,000 of Johnson & Johnson
Creator: Capitol Markets

Trade dated Mar 19, 202626 days to disclose

JNJ since the sale

-4.0%

S&P 500, same window

+14.7%

▼ JNJ trailed the S&P 500 by 18.7 points since the sale

Price move from the trade date's close to the most recent close. A sale is favorable when the stock fell after.

On the public record around this trade

Committee activity, sponsored or cosponsored bills, and floor votes in this sector within 90 days — alongside the trade and its disclosure. Dated public record; draw your own conclusions.

Jan 27, 2026Legislation
Cosponsored S 3492
Pharmaceutical sector
Jan 30, 2026Legislation
Cosponsored SRES 590
Pharmaceutical sector
Feb 10, 2026Legislation
Cosponsored S 1141
Pharmaceutical sector
Mar 3, 2026Legislation
Sponsored S 1918
Pharmaceutical sector
Mar 19, 2026Trade
Sold up to $15,000 of JNJ
Apr 14, 2026Disclosure
Disclosed the trade
Public filing
May 11, 2026Legislation
Cosponsored S 4233
Pharmaceutical sector
May 12, 2026Committee
Committee on Agriculture, Nutrition, and Forestry hearing
Hearings to examine perspectives on the fertilizer industry, focusing on ensuring a stable and affordable supply for American producers.
May 13, 2026Committee
Committee on Environment and Public Works hearing
Hearings to examine the President's proposed budget request for fiscal year 2027 for the U.S. Nuclear Regulatory Commission.
May 13, 2026Committee
Committee on Veterans' Affairs hearing
Hearings to examine VA police operations.

Source: U.S. Senate (efdsearch.senate.gov)

Get an alert the moment John Boozman files the next one

Capitol Markets tracks every Member of Congress in plain English — the trade, the price move, the committee overlap, the source filing.

Get filing alerts See all of Boozman's trades